Confido Health's Series A Lifts Total Funding to $22.5 Million

Confido Health has raised a Series A round that brings its total funding to $22.5 million, money the company will use to expand its agentic healthcare operations platform, Pulse 2.0 reports.

The number is the headline: $22.5 million in total backing, with the new Series A tranche layered on top of earlier investment. Confido Health isn't disclosing a standalone figure for this round in the announcement covered by Pulse 2.0, but the cumulative total signals investor appetite for software that automates the operational grunt work inside healthcare organizations.

What does Confido Health actually build?

The company describes its product as an "agentic healthcare operations platform." In practical terms, that means AI-driven agents that handle repetitive administrative workflows — the scheduling, follow-ups, documentation and coordination tasks that consume staff hours across clinics and provider groups.

Healthcare operations have become a crowded corner of the software market, and Confido Health is betting that agentic AI — systems that don't just answer questions but take actions — is the next step beyond the workflow tools providers already use. The Series A cash is earmarked for expanding exactly that platform, per Pulse 2.0's report.

Who put money in?

Pulse 2.0's coverage centers on the funding total and the company's expansion plans rather than a full investor roster or valuation. What's confirmed: the round is a Series A, it closes Confido Health's total raise at $22.5 million, and the capital supports scaling the agentic operations platform.

Series A rounds of this cumulative size typically fund a few concrete priorities, and Confido Health's stated use of proceeds fits the pattern:

• Expanding the agentic platform's capabilities and coverage
• Growing the team that builds and deploys it
• Deepening reach among healthcare operators drowning in administrative overhead

Why does agentic AI matter in healthcare admin?

Healthcare remains one of the most administratively bloated industries in the economy. Providers spend heavily on billing, prior authorization, patient communication and care coordination — tasks that are rule-heavy, repetitive and ripe for automation.

Agentic AI platforms attack that cost base differently than classic workflow software. Instead of giving staff another dashboard, agents execute multi-step processes end to end. For a healthcare operator, that's the difference between a tool that reminds a person to call a patient and a system that handles the scheduling loop itself.

That pitch has drawn venture dollars across the sector, and Confido Health's $22.5 million total places it among the funded contenders. The company now has to prove its agents can perform reliably in environments where errors carry compliance and patient-safety consequences.

What comes next?

The immediate plan, per Pulse 2.0, is expansion — broader platform capability, more deployments, more scale. The $22.5 million war chest gives Confido Health runway to do it without rushing to raise again.

The test ahead is retention and measurable cost savings for healthcare clients. If Confido Health's agents can prove they cut administrative hours and improve throughput, the Series A won't be its last round; if they can't, the agentic label alone won't carry the company much further.

By Amara Osei